Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

Vida Therapeutics Inc.

viDA Therapeutics is advancing first-in-class drugs based on inhibitors of the extracellular serine protease, Granzyme B, to treat autoimmune and chronic inflammatory diseases. The company is focused on advancing their lead candidate into the clinic.

Investment year: 2012
Industry sector: Biotechnology
Region: Prairies and West
BDC Venture Capital Partner

Dominique Bélanger

Managing Partner